Advances in Skin Regeneration Using Tissue Engineering

Tissue engineered skin substitutes for wound healing have evolved tremendously over the last couple of years. New advances have been made toward developing skin substitutes made up of artificial and natural materials. Engineered skin substitutes are developed from acellular materials or can be synthesized from autologous, allograft, xenogenic, or synthetic sources. Each of these engineered skin substitutes has their advantages and disadvantages. However, to this date, a complete functional skin substitute is not available, and research is continuing to develop a competent full thickness skin substitute product that can vascularize rapidly. There is also a need to redesign the currently available substitutes to make them user friendly, commercially affordable, and viable with longer shelf life. The present review focuses on providing an overview of advances in the field of tissue engineered skin substitute development, the availability of various types, and their application.

[1]  K. Harding,et al.  Efficacy and safety of the freeze‐dried cultured human keratinocyte lysate, LyphoDerm™ 0.9%, in the treatment of hard‐to‐heal venous leg ulcers , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[2]  T. Phillips,et al.  Current Approaches to Venous Ulcers and Compression , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[3]  H. Carsin,et al.  Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. , 2000, Burns : journal of the International Society for Burn Injuries.

[4]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[5]  M. Jeschke,et al.  A comparison of Biobrane™ and cadaveric allograft for temporizing the acute burn wound: Cost and procedural time. , 2015, Burns : journal of the International Society for Burn Injuries.

[6]  P. Fratino,et al.  HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. , 2003, Diabetes care.

[7]  J. Hansbrough,et al.  Direct comparison of a cultured composite skin substitute containing human keratinocytes and fibroblasts to an epidermal sheet graft containing human keratinocytes on athymic mice. , 1993, The Journal of investigative dermatology.

[8]  J. Raguse,et al.  The buccal fad pad lined with a metabolic active dermal replacement (Dermagraft) for treatment of defects of the buccal plane. , 2004, British journal of plastic surgery.

[9]  S. Myers,et al.  The Role of Hyaluronic Acid in Wound Healing , 2005, American journal of clinical dermatology.

[10]  B. Tan,et al.  Early Experience with Biobrane™ in Singapore in the Management of Partial Thickness Burns , 2014 .

[11]  A. Halim,et al.  Dried irradiated human amniotic membrane as a biological dressing for facial burns--a 7-year case series. , 2010, Burns : journal of the International Society for Burn Injuries.

[12]  R. Tuan,et al.  Concise Review: Clinical Translation of Wound Healing Therapies Based on Mesenchymal Stem Cells , 2012, Stem cells translational medicine.

[13]  Adil Akkouch,et al.  Bioactivating electrically conducting polypyrrole with fibronectin and bovine serum albumin. , 2010, Journal of biomedical materials research. Part A.

[14]  Alessandra Pavesio,et al.  Epidermal homeostasis in long-term scaffold-enforced skin equivalents. , 2006, The journal of investigative dermatology. Symposium proceedings.

[15]  M. Jeschke,et al.  The use of dermal substitutes in burn surgery: Acute phase , 2014, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[16]  C. Soranzo,et al.  Hyalomatrix: a temporary epidermal barrier, hyaluronan delivery, and neodermis induction system for keratinocyte stem cell therapy. , 2007, Tissue engineering.

[17]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[18]  S. Kundu,et al.  Skin Equivalent Tissue-Engineered Construct: Co-Cultured Fibroblasts/ Keratinocytes on 3D Matrices of Sericin Hope Cocoons , 2013, PloS one.

[19]  P. Norman,et al.  Immunobiology: The immune system in health and disease , 1995 .

[20]  S. Boyce,et al.  The 1999 clinical research award. Cultured skin substitutes combined with Integra Artificial Skin to replace native skin autograft and allograft for the closure of excised full-thickness burns. , 1999, The Journal of burn care & rehabilitation.

[21]  P. Dziewulski,et al.  The use of Biobrane® to dress split-thickness skin graft in paediatric burns. , 2013, Annals of burns and fire disasters.

[22]  J. M. Centanni,et al.  Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute. , 2009, The Journal of trauma.

[23]  J. Few,et al.  The Use of Biosynthetic Skin Substitute (Biobrane) for Axillary Reconstruction after Surgical Excision for Hidradenitis Suppurativa , 2005, Plastic and reconstructive surgery.

[24]  J. Wasiak,et al.  Effective use of Biobrane as a temporary wound dressing prior to definitive split-skin graft in the treatment of severe burn: A retrospective analysis. , 2015, Burns : journal of the International Society for Burn Injuries.

[25]  Koon Gee Neoh,et al.  Plasma protein adsorption and thrombus formation on surface functionalized polypyrrole with and without electrical stimulation. , 2004, Journal of colloid and interface science.

[26]  Kyongbum Lee,et al.  Vascularization strategies for tissue engineering. , 2009, Tissue engineering. Part B, Reviews.

[27]  B. Atiyeh,et al.  Cultured epithelial autograft (CEA) in burn treatment: three decades later. , 2007, Burns : journal of the International Society for Burn Injuries.

[28]  D Zuder,et al.  Current therapies for wound healing: electrical stimulation, biological therapeutics, and the potential for gene therapy , 1999, International journal of dermatology.

[29]  P. V. van Zuijlen,et al.  Graft Survival and Effectiveness of Dermal Substitution in Burns and Reconstructive Surgery in a One-Stage Grafting Model , 2000, Plastic and reconstructive surgery.

[30]  Robert J Snyder,et al.  Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial , 2012, The Lancet.

[31]  J. Mulliken,et al.  GRAFTING OF BURNS WITH CULTURED EPITHELIUM PREPARED FROM AUTOLOGOUS EPIDERMAL CELLS , 1981, The Lancet.

[32]  S. Badylak,et al.  Porcine small intestinal submucosa (SIS): a bioscaffold supporting in vitro primary human epidermal cell differentiation and synthesis of basement membrane proteins. , 2001, Burns : journal of the International Society for Burn Injuries.

[33]  D. Supp,et al.  Expression of human beta-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes. , 2004, Burns : journal of the International Society for Burn Injuries.

[34]  H Green,et al.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. , 1975, Cell.

[35]  S. E. James,et al.  A review of tissue-engineered skin bioconstructs available for skin reconstruction , 2010, Journal of The Royal Society Interface.

[36]  K. Ghosh,et al.  Tissue engineering for cutaneous wounds. , 2007, The Journal of investigative dermatology.

[37]  S. Yıldırım,et al.  An Alternative Method to Minimize Pain in the Split-Thickness Skin Graft Donor Site , 2003, Plastic and reconstructive surgery.

[38]  S. Boyce,et al.  Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. , 2002, American journal of surgery.

[39]  Peter G Shakespeare,et al.  The role of skin substitutes in the treatment of burn injuries. , 2005, Clinics in dermatology.

[40]  B. Tan,et al.  Skin tissue engineering advances in severe burns: review and therapeutic applications , 2016, Burns & Trauma.

[41]  David J. Anderson,et al.  Electrochemical deposition and characterization of conducting polymer polypyrrole/PSS on multichannel neural probes , 2001 .

[42]  J P Hodde,et al.  An investigation of the long-term bioactivity of endogenous growth factor in OASIS Wound Matrix. , 2005, Journal of wound care.

[43]  K. B. Hellman Engineered tissues: the regulatory path from concept to market. , 2006, Advances in experimental medicine and biology.

[44]  M. Ferguson,et al.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration , 2007, Journal of The Royal Society Interface.

[45]  G. Plosker,et al.  Bilayered Bioengineered Skin Substitute (Apligraf®) , 2012, BioDrugs.

[46]  Y. Bello,et al.  Tissue‐Engineered Skin in the Healing of Wound Stumps from Limb Amputations Secondary to Purpura Fulminans , 2003, Pediatric dermatology.

[47]  T. Crombleholme,et al.  The Role of Stem Cells in Wound Angiogenesis. , 2014, Advances in wound care.

[48]  Elaine Fuchs,et al.  Stem cells of the skin epithelium , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Anne-Katrin Bock,et al.  Human tissue-engineered products-Today ’ s markets and future prospects , 2003 .

[50]  John E. Greenwood,et al.  Experience With Biobrane: Uses and Caveats for Success , 2009, Eplasty.

[51]  John P Fisher,et al.  Biomaterial Scaffolds in Pediatric Tissue Engineering , 2008, Pediatric Research.

[52]  B. Woodward,et al.  The use of cultured autologous keratinocytes with integra in the resurfacing of acute burns. , 1998, Plastic and reconstructive surgery.

[53]  N. Howe,et al.  Skin substitutes: an overview of the key players in wound management. , 2014, The Journal of clinical and aesthetic dermatology.

[54]  D. Supp,et al.  Engineered skin substitutes: practices and potentials. , 2005, Clinics in dermatology.

[55]  D. Herndon,et al.  The Search for an Ideal Temporary Skin Substitute: AWBAT Plus, a Combination Product Wound Dressing Medical Device , 2010, Eplasty.

[56]  Amy Li,et al.  Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny. , 2004, The Journal of clinical investigation.

[57]  Santos,et al.  Skin substitutes : current concepts and a new classification system , 2012 .

[58]  R. Snyder,et al.  Scientific and clinical support for the use of dehydrated amniotic membrane in wound management. , 2012, Wounds : a compendium of clinical research and practice.

[59]  G. Piérard,et al.  Tapping into the Influence of Keratinocyte Allografts and Biocenosis on Healing of Chronic Leg Ulcers: Split‐Ulcer Controlled Pilot Study , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[60]  D. Salomon,et al.  An autologous epidermal equivalent tissue‐engineered from follicular outer root sheath keratinocytes is as effective as split‐thickness skin autograft in recalcitrant vascular leg ulcers , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[61]  Marcus Castro Ferreira,et al.  Substitutos cutâneos: conceitos atuais e proposta de classificação , 2011 .

[62]  R. Short,et al.  Plasma-polymerized surfaces for culture of human keratinocytes and transfer of cells to an in vitro wound-bed model. , 2003, Journal of biomedical materials research. Part A.

[63]  Katja Schenke-Layland,et al.  Skin tissue engineering--in vivo and in vitro applications. , 2011, Advanced drug delivery reviews.

[64]  C. V. van Blitterswijk,et al.  Bilayered biodegradable poly(ethylene glycol)/poly(butylene terephthalate) copolymer (Polyactive) as substrate for human fibroblasts and keratinocytes. , 1999, Journal of biomedical materials research.

[65]  Skin explant cultures as a source of keratinocytes for cultivation , 2013, Cell and Tissue Banking.

[66]  E. Dellambra,et al.  Tissue engineering for damaged surface and lining epithelia: stem cells, current clinical applications, and available engineered tissues. , 2009, Tissue engineering. Part B, Reviews.

[67]  Subhas C. Gupta,et al.  Skin Substitutes and Alternatives: A Review , 2007, Advances in skin & wound care.

[68]  B. Dréno,et al.  Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy , 2013, PloS one.

[69]  H. Green,et al.  Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes , 1977, Nature.

[70]  J. Still,et al.  The use of a collagen sponge/living cell composite material to treat donor sites in burn patients. , 2003, Burns : journal of the International Society for Burn Injuries.

[71]  K. Harding,et al.  Psychological Factors and Delayed Healing in Chronic Wounds , 2001, Psychosomatic medicine.

[72]  S. Rabiee,et al.  The Healing Effect of Amniotic Membrane in Burn Patients , 2016, World journal of plastic surgery.

[73]  K. Carroll,et al.  Human Skin Allograft Used to Treat Open Wounds After Club Foot Release , 2003, Annals of plastic surgery.

[74]  R. Barrow,et al.  A Comparison of Conservative Versus Early Excision: Therapies in Severely Burned Patients , 1989, Annals of surgery.

[75]  N. Fortunel,et al.  Functional investigations of keratinocyte stem cells and progenitors at a single-cell level using multiparallel clonal microcultures. , 2010, Methods in molecular biology.

[76]  Ulrich Kneser,et al.  Tissue engineering of cultured skin substitutes , 2005, Journal of cellular and molecular medicine.

[77]  E. Rolland,et al.  Wound Stimulation by Growth-Arrested Human Keratinocytes and Fibroblasts: HP802-247, a New-Generation Allogeneic Tissue Engineering Product , 2010, Dermatology.

[78]  P. Kim,et al.  Bioengineered alternative tissues and hyperbaric oxygen in lower extremity wound healing. , 2007, Clinics in podiatric medicine and surgery.

[79]  S. Boyce,et al.  Autologous cultured skin substitutes conserve donor autograft in elective treatment of congenital giant melanocytic nevus. , 2004, Plastic and reconstructive surgery.

[80]  K. Woodhouse,et al.  Characterization of biodegradable polyurethane microfibers for tissue engineering , 2007, Journal of biomaterials science. Polymer edition.

[81]  Kavita Vedhara,et al.  Psychological stress and wound healing in humans: a systematic review and meta-analysis. , 2009, Journal of psychosomatic research.

[82]  C. Attinger,et al.  Serial surgical debridement: A retrospective study on clinical outcomes in chronic lower extremity wounds , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[83]  E. Tredget,et al.  Advances in Skin Substitutes—Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing , 2015, Journal of functional biomaterials.

[84]  A. de Mel,et al.  Orchestrating cell/material interactions for tissue engineering of surgical implants. , 2012, Macromolecular bioscience.

[85]  M. Límová Active wound coverings: bioengineered skin and dermal substitutes. , 2010, The Surgical clinics of North America.

[86]  W. Ho,et al.  Skin substitutes: An overview , 2002 .

[87]  L W Rue,et al.  Wound closure and outcome in extensively burned patients treated with cultured autologous keratinocytes. , 1992, The Journal of trauma.

[88]  • Epidermis,et al.  WOUND healing. , 1959, The Medical journal of Australia.

[89]  F. Wood,et al.  Cultured Autologous Keratinocytes in Suspension Accelerate Epithelial Maturation in an In Vivo Wound Model as Measured by Surface Electrical Capacitance , 2007, Plastic and reconstructive surgery.

[90]  D. Hutmacher,et al.  Reduced contraction of skin equivalent engineered using cell sheets cultured in 3D matrices. , 2006, Biomaterials.

[91]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[92]  L. Alrubaiy,et al.  Skin substitutes: a brief review of types and clinical applications. , 2009, Oman medical journal.

[93]  Sheila MacNeil,et al.  Progress and opportunities for tissue-engineered skin , 2007, Nature.

[94]  B. Atiyeh,et al.  Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. , 2002, Current pharmaceutical biotechnology.

[95]  Paul G Scott,et al.  Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.

[96]  G. Plosker,et al.  Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers. , 2002, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

[97]  J. Rheinwald Human epidermal keratinocyte cell culture and xenograft systems: applications in the detection of potential chemical carcinogens and the study of epidermal transformation. , 1989, Progress in clinical and biological research.

[98]  P. Shakespeare,et al.  Survey: use of skin substitute materials in UK burn treatment centres. , 2002, Burns : journal of the International Society for Burn Injuries.

[99]  Michael J Yost,et al.  Novel therapies for scar reduction and regenerative healing of skin wounds. , 2008, Trends in biotechnology.

[100]  L. Uccioli A Clinical Investigation on the Characteristics and Outcomes of Treating Chronic Lower Extremity Wounds using the TissueTech Autograft System , 2003, The international journal of lower extremity wounds.

[101]  D. Armstrong,et al.  Bioengineered tissues in wound healing: a progress report , 2011 .

[102]  M. Conconi,et al.  Tracheal matrices, obtained by a detergent‐enzymatic method, support in vitro the adhesion of chondrocytes and tracheal epithelial cells , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[103]  C. Compton,et al.  Permanent coverage of large burn wounds with autologous cultured human epithelium. , 1985, The New England journal of medicine.

[104]  R. Yetman,et al.  Autologous Inferior Dermal Sling (Autoderm) with Concomitant Skin-Envelope Reduction Mastectomy: An Excellent Surgical Choice for Women with Macromastia and Clinically Significant Ptosis , 2012, Annals of Surgical Oncology.

[105]  S. Przyborski,et al.  A Novel Fully Humanized 3D Skin Equivalent to Model Early Melanoma Invasion , 2015, Molecular Cancer Therapeutics.

[106]  J. Davis,et al.  ADDRESS OF THE PRESIDENT: THE STORY OF PLASTIC SURGERY , 1941 .

[107]  H. Cleland,et al.  Bioengineered skin substitutes for the management of burns: a systematic review. , 2007, Burns : journal of the International Society for Burn Injuries.

[108]  Sheila MacNeil,et al.  Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents. , 2006, Journal of biotechnology.

[109]  Sharon Gerecht,et al.  Engineered Biopolymeric Scaffolds for Chronic Wound Healing , 2016, Front. Physiol..

[110]  J. Hansbrough,et al.  Safety and efficacy of TransCyte for the treatment of partial-thickness burns. , 1999, The Journal of burn care & rehabilitation.

[111]  H. Ryssel,et al.  The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns--a pilot study. , 2008, Burns : journal of the International Society for Burn Injuries.

[112]  R. Isseroff,et al.  Cellular versus acellular matrix devices in treatment of diabetic foot ulcers: study protocol for a comparative efficacy randomized controlled trial , 2013, Trials.

[113]  A. Halim,et al.  Biologic and synthetic skin substitutes: An overview , 2010, Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India.

[114]  E. A. Woodroof The Search for an Ideal Temporary Skin Substitute: AWBAT , 2009, Eplasty.

[115]  Yan Jin,et al.  Enrichment of epidermal stem cells by rapid adherence and analysis of the reciprocal interaction of epidermal stem cells with neighboring cells using an organotypic system , 2007, Cell biology international.

[116]  Aaron D. Levine,et al.  Challenges in the translation and commercialization of cell therapies , 2015, BMC Biotechnology.

[117]  J. M. Centanni,et al.  StrataGraft Skin Substitute Is Well-tolerated and Is Not Acutely Immunogenic in Patients With Traumatic Wounds: Results From a Prospective, Randomized, Controlled Dose Escalation Trial , 2011, Annals of surgery.

[118]  J. Hicks,et al.  A comparative, long term assessment of soft tissue substitutes: AlloDerm, Enduragen, and Dermamatrix. , 2009, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[119]  V. Falanga,et al.  The emerging use of bone marrow-derived mesenchymal stem cells in the treatment of human chronic wounds , 2013, Expert opinion on emerging drugs.

[120]  B. Cullen The role of oxidized regenerated cellulose/collagen in chronic wound repair. Part 2. , 2002, Ostomy/wound management.

[121]  N. Fusenig,et al.  Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents. , 2007, European journal of cell biology.

[122]  Bioinspired Polymeric Surface Patterns for Medical Applications , 2012, Journal of applied biomaterials & functional materials.

[123]  Y. Bello,et al.  Tissue-engineered skin. Current status in wound healing. , 2001, American journal of clinical dermatology.

[124]  P. M. Vogt,et al.  [Dermal subsitute with the collagen-elastin matrix Matriderm in burn injuries: a comprehensive review]. , 2008, Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V....

[125]  T. Darling,et al.  Alteration of Skin Properties with Autologous Dermal Fibroblasts , 2014, International journal of molecular sciences.

[126]  M. Schäfer-Korting,et al.  The Phenion® Full-Thickness Skin Model for Percutaneous Absorption Testing , 2009, Skin Pharmacology and Physiology.